Covolon cultures cells on collagen scaffold

Mississauga - Covalon Technologies Ltd. has successfully cultured cells on its collagen-based scaffold. Collagen and gelatin, once prepared, using Covalon's proprietary technologies, form a matrix (scaffold) that is biocompatible and biodegradable. The materials are useful as wound dressings, as supports for tissue regeneration, and the delivery of drugs.

"The successful growth of animal cells on Covalon's proprietary cellular scaffold demonstrates that the matrix is well accepted. The cells adhere and grow very well on the matrix," stated Frank DiCosmo, Covalon's CEO.

Covalon has developed collagen-based wound care products for reducing the incidence of Hospital -Acquired Infections (HAI) for wounds using the collagen scaffold. Polymer chemistry and surface coating technology have been combined to create a range of time-release drug delivery platforms that are applied to many medical devices to treat many critical conditions. A variety of applications for these technologies have been identified and specific products have been developed. The products offer features and benefits providing solutions to many of the problems caused by current devices and their material properties that are used by most medical device manufacturers and suppliers.